21 CFR § 58.41 - General.

---
identifier: "/us/cfr/t21/s58.41"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 58.41 - General."
title_number: 21
title_name: "Food and Drugs"
section_number: "58.41"
section_name: "General."
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "A"
subchapter_name: "GENERAL"
part_number: "58"
part_name: "GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 342, 346, 346a, 348, 351, 352, 353, 355, 360, 360b-360f, 360h-360j, 371, 379e, 381; 42 U.S.C. 216, 262, 263b-263n."
regulatory_source: "43 FR 60013, Dec. 22, 1978, unless otherwise noted."
cfr_part: "58"
---


# 58.41 General.

Each testing facility shall be of suitable size and construction to facilitate the proper conduct of nonclinical laboratory studies. It shall be designed so that there is a degree of separation that will prevent any function or activity from having an adverse effect on the study.

[52 FR 33780, Sept. 4, 1987]